内科治疗后缓解的Ｃｒｏｈｎ病病人中,30%～60%会在1年内复发。对有复发高风险病人能否作出识别将会影响维持缓解治疗的成败。为此作者研究了处于缓解的Ｃｒｏｈｎ病病人结肠固有膜中单核细胞的肿瘤坏死因子(ＴＮＦα)、白介素1β(ＩＬβ)生成量与疾病复发风险之间的关系。病人 30% to 60% of patients with Crohn disease who have been relieved after medical treatment will relapse within 1 year. The identification of patients at high risk of recurrence will affect the success or failure of maintenance treatment. To this end, the authors investigated the relationship between the levels of tumor necrosis factor (TNFα), interleukin-1β (ILβ), and the risk of recurrent disease in mononuclear cells of the colon lamina propria of Crohn’s disease patients in remission. patient